DYN

About Dyne Therapeutics, Inc. Common Stock (DYN) Stock

Dyne Therapeutics, Inc. Common Stock (DYN) closed the 2026-09-17 session at $18.06, up 4.36% versus the previous close (+0.75). The stock opened at $17.90 and traded between $17.62 and $18.11 during that session. Session trading volume was 2.8M shares. The volume-weighted average price (VWAP) is $17.87.

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

Dyne Therapeutics, Inc. Common Stock has a market capitalization of $3.23 billion. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. DYN is listed on the XNAS exchange. The company employs approximately 258 people. Dyne Therapeutics, Inc. Common Stock is headquartered in WALTHAM, MA. The recorded listing date is 2020-09-17.

On this page you can find market DYN stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.

Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.